HNN3.0
Register
Register
Register

Project cooperationUpdated on 19 January 2026

HORIZON-HLTH-2026-03-DISEASE-13 _European Partnership for Pandemic Preparedness (Phase 2)

Project Scientist/ Alumni Spingler Lab at University of Zurich/ Department of Chemistry/ Phototherapeutics

Zurich, Switzerland

About

OBJECTIVES & IMPACT

PDT/PTT suported Host-Directed Therapy with Kinase Inhibitors. Enable hypoxia-active phototherapeutic combination therapies that overcome efficacy limits of HDT

OUR EXPERTISE

•Design and optimization of BODIPY-based PDT/PTT agents with exceptional light-to-dark toxicity ratios

•Design and optimization of conjugates of BODIPY-kinase inhibitors

EXTERNAL EXPERTISE SOUGHT

•Disease biology and in vivo models (infectious diseases, AMR)

•Kinase libraries for BODIPY conjugation

•Access to BSL-2/3/4 facilities

ROLE DECLARATION

•Partner for design,  optimization of chemical structures and their realization in a suitable quantity and quality

•Coordinator for adjacent WPs

Organisation

Similar opportunities